Patrys Ltd has released a press release.
$4.29 Million Fully Underwritten Rights Issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Patrys
- Investor Presentation - June 2020
- Appendix 4C - Quarterly - 31 March 2020
- PAT-DX1 mechanism for crossing blood brain barrier confirmed
- PAT-DX1-NP crosses BBB and targets tumours
- Appendix 4D - Half Year Accounts - 31 December 2019
Later from Patrys
- Appendix 4C - Quarterly - 30 June 2020
- Entitlement Offer Results and Shortfall Notification
- Appendix 4E and 2020 Annual Report
- Patrys adds full human antibody to Deoxymab portfolio
- First patent granted for Deoxymab-nanoparticles
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys